OncoGenex to Regain Rights to Custirsen from Teva By: Benzinga via Benzinga December 30, 2014 at 07:03 AM EST OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that it has executed an initial agreement with Teva Pharmaceutical ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR